{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:18:49Z","timestamp":1773983929867,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>External beam radiation in the mantle field has been a mainstay of therapy for Hodgkin's lymphoma for decades. The incidence of breast cancer in patients treated with mantle radiation is known to be elevated. Few studies have examined outcomes of breast reconstruction in this high-risk group. The current study presents the largest series of immediate breast reconstruction in this population and aims to evaluate reconstructive outcomes and examine differences between implant-based and autologous reconstructions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective review of records from a 10-year period at 2 institutions was undertaken. Patients treated with mantle radiation for Hodgkin's lymphoma who subsequently underwent mastectomy with immediate reconstruction were identified. Patient demographics, clinical characteristics, and outcomes including complications and operative revisions were gathered. Univariate and multivariate analyses were conducted to assess differences between implant-based and autologous reconstructions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 97 breast reconstructions were performed in 52 patients. Seventy-nine reconstructions were implant-based, and 18 were autologous. Patients with implant-based reconstructions were older than autologous reconstructions (47 \u00b1 8.8 years vs 42 \u00b1 6.5 years, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Both groups had long-term follow-up; however, the mean follow-up duration was shorter in the implant-based compared with the autologous group (5 years vs 8.3 years; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Otherwise, the groups were similar with respect to BMI, medical comorbidities, oncologic diagnosis, and therapy. The interval between mantle radiation and reconstruction was comparable for implant-based and autologous groups (23.4 \u00b1 9 years vs 21.3 \u00b1 6.1 years, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.6). The overall complication rate of breast reconstruction was not statistically different between the implant-based and autologous groups (35% vs 16%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.16). Three implant-based reconstructions (3.7%) required explantation. There were no complete flap losses in the autologous group. An associated 6-fold higher rate of unplanned revisions was observed with the autologous reconstruction group compared with the implant-based reconstruction group (odds ratio, 6.09; 95% confidence interval, 1.14\u201332.48; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.035).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this study, long-term follow-up suggests immediate breast reconstruction in patients with prior mantle radiation can be achieved safely with an acceptable complication profile utilizing either implant-based or autologous techniques. Autologous breast reconstruction is linked with a higher rate of revisions compared with implant-based breast reconstruction in this study population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000002087","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T17:43:06Z","timestamp":1572889386000},"page":"507-511","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes Following Breast Reconstruction in Patients With Prior Mantle Radiation for Treatment of Hodgkin's Lymphoma"],"prefix":"10.1097","volume":"84","author":[{"given":"Brian","family":"Freniere","sequence":"first","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Irwin","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Guldbrandsen","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily H.","family":"Lafleur","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dominici","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sturgeon","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon S.","family":"Chun","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230923","first-page":"485071","article-title":"The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?","volume":"2015","year":"2015","journal-title":"Biomed Res Int"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1517\/14656566.2010.515979","article-title":"Hodgkin's lymphoma therapy: past, present, and future","volume":"11","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"bib3-20230923","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2016.05.008","article-title":"Hodgkin lymphoma: late effects of treatment and guidelines for surveillance","volume":"53","year":"2016","journal-title":"Semin Hematol"},{"key":"bib4-20230923","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1245\/s10434-013-3284-z","article-title":"A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"575e","DOI":"10.1097\/PRS.0000000000002532","article-title":"Impact of prior unilateral chest wall radiotherapy on outcomes in bilateral breast reconstruction","volume":"138","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00006534-200201000-00017","article-title":"Breast reconstruction using tissues expanders and implants in Hodgkin's patients with prior mantle irradiation","volume":"109","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/SAP.0000000000000167","article-title":"Outcomes of breast reconstruction in breast cancer patients with a history of mantle radiation for Hodgkin lymphoma","volume":"72","year":"2014","journal-title":"Ann Plast Surg"},{"key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/SLA.0000000000002033","article-title":"Complications in postmastectomy breast reconstruction. One-year Outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) Study","volume":"267","year":"2018","journal-title":"Ann Surg"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/PRS.0000000000004362","article-title":"Quality of surgical outcomes reporting in plastic surgery: a 15-year analysis of complication data","volume":"141","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1097\/SAP.0000000000001382","article-title":"Complications after two-stage expander implant breast reconstruction requiring reoperation: a critical analysis of outcomes","volume":"80","year":"2018","journal-title":"Ann Plast Surg"},{"key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PRS.0b013e31823ae8b1","article-title":"Outcomes of tissue expander\/implant breast reconstruction in the setting of prereconstruction radiation","volume":"129","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0360-3016(97)00026-6","article-title":"The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib15-20230923","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jnci\/djx148","article-title":"Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction","volume":"110","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejmp.2018.12.036","article-title":"Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkins disease","volume":"57","year":"2019","journal-title":"Phys Med"},{"key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pbc.24861","article-title":"The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma","volume":"61","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"bib19-20230923","first-page":"2","article-title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk","volume":"15","year":"2007","journal-title":"Radiat Oncol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T05:13:33Z","timestamp":1695446013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000002087","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}